[Form 4] Johnson & Johnson Insider Trading Activity
Insider transaction summary for Johnson & Johnson (JNJ): Elizabeth Forminard, Executive VP and General Counsel, reported option-related activity on 08/29/2025. She exercised 11,521 employee stock options with an exercise price of $115.67, acquiring 11,521 shares at that price. Following the exercise, she sold 9,570 shares at $177.20, leaving her beneficial ownership at 12,853 shares of common stock. The options exercised were originally granted on 02/13/2020 and vested to be exercisable on the third anniversary of the grant; their expiration date is 02/13/2027. The Form 4 was signed by an attorney-in-fact on 09/03/2025.
Riepilogo delle operazioni di insider per Johnson & Johnson (JNJ): Elizabeth Forminard, Executive VP e General Counsel, ha riportato un'operazione relativa a opzioni il 29/08/2025. Ha esercitato 11.521 stock option per dipendenti con prezzo di esercizio di $115,67, acquisendo quindi 11.521 azioni a tale prezzo. Dopo l'esercizio ha venduto 9.570 azioni a $177,20, mantenendo una partecipazione beneficiaria pari a 12.853 azioni ordinarie. Le opzioni erano state originariamente assegnate il 13/02/2020, erano divenute esercitabili al terzo anniversario della concessione e scadono il 13/02/2027. Il modulo Form 4 猫 stato firmato da un procuratore il 03/09/2025.
Resumen de transacciones de insiders de Johnson & Johnson (JNJ): Elizabeth Forminard, Vicepresidenta Ejecutiva y Consejera General, inform贸 actividad relacionada con opciones el 29/08/2025. Ejerci贸 11.521 opciones sobre acciones de empleados con un precio de ejercicio de $115,67, adquiriendo 11.521 acciones a ese precio. Tras el ejercicio vendi贸 9.570 acciones a $177,20, quedando con una titularidad beneficiosa de 12.853 acciones ordinarias. Las opciones fueron otorgadas originalmente el 13/02/2020, se hicieron ejercitables en el tercer aniversario de la concesi贸n y vencen el 13/02/2027. El Formulario 4 fue firmado por un apoderado el 03/09/2025.
Johnson & Johnson(JNJ) 雮措秬鞛� 瓯半灅 鞖旍暯: Elizabeth Forminard(鞝勲 瓴� 氩曤齑濌磩)電� 2025-08-29鞐� 鞓奠厴 甏�霠� 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟. 攴鸽厐電� 頄夓偓臧�瓴� $115.67鞚� 歆侅洂 鞀ろ啞鞓奠厴 11,521欤茧ゼ 頄夓偓頃橃棳 頃措嫻 臧�瓴╈溂搿� 11,521欤茧ゼ 旆摑頄堨姷雼堧嫟. 頄夓偓 頉� 9,570欤茧ゼ 欤茧嫻 $177.20鞐� 毵る弰頃橃棳, 氤挫湢 鞙犾澋甓岇潃 氤错喌欤� 12,853欤茧 雮晿鞀惦媹雼�. 頃措嫻 鞓奠厴鞚� 2020-02-13鞐� 攵�鞐悩鞐堦碃 攵�鞐澕搿滊秬韯� 3欤茧厔 鞁滌爯鞐� 頄夓偓 臧�電ロ晿霃勲 氩犾姢韺呺悩鞐堨溂氅� 毵岅赴鞚检潃 2027-02-13鞛呺媹雼�. Form 4電� 2025-09-03鞐� 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.
R茅sum茅 des transactions d'initi茅s pour Johnson & Johnson (JNJ) : Elizabeth Forminard, vice-pr茅sidente ex茅cutive et conseill猫re g茅n茅rale, a d茅clar茅 une op茅ration li茅e 脿 des options le 29/08/2025. Elle a exerc茅 11 521 options sur actions des salari茅s au prix d'exercice de 115,67 $, acqu茅rant ainsi 11 521 actions 脿 ce prix. Apr猫s l'exercice, elle a vendu 9 570 actions 脿 177,20 $, laissant une participation b茅n茅ficiaire de 12 853 actions ordinaires. Les options exer莽茅es avaient 茅t茅 attribu茅es initialement le 13/02/2020, devenaient exer莽ables au troisi猫me anniversaire de l'attribution et expirent le 13/02/2027. Le formulaire Form 4 a 茅t茅 sign茅 par un mandataire le 03/09/2025.
Insider-Transaktions眉bersicht f眉r Johnson & Johnson (JNJ): Elizabeth Forminard, Executive VP und General Counsel, meldete am 29.08.2025 eine transaktion im Zusammenhang mit Optionen. Sie 眉bte 11.521 Mitarbeiteraktienoptionen zum Aus眉bungspreis von $115,67 aus und erwarb damit 11.521 Aktien zu diesem Preis. Nach der Aus眉bung verkaufte sie 9.570 Aktien zu $177,20 und behielt eine wirtschaftliche Beteiligung von 12.853 Stammaktien. Die ausge眉bten Optionen wurden urspr眉nglich am 13.02.2020 gew盲hrt, wurden am dritten Jahrestag der Gew盲hrung aus眉bbar und laufen am 13.02.2027 ab. Das Formular Form 4 wurde am 03.09.2025 von einem Bevollm盲chtigten unterzeichnet.
- Exercise and partial sale executed and reported timely: Transactions on 08/29/2025 were disclosed and Form 4 was signed 09/03/2025.
- AG真人官方ized gain per sold share: Sale at $177.20 versus exercise price $115.67 shows a clear per-share spread of $61.53.
- Reduction in insider ownership: Disposition of 9,570 shares reduced direct beneficial holdings to 12,853 shares.
- No indication of a 10b5-1 plan in the filing text: The form does not check the box indicating the transaction was pursuant to a pre-arranged plan.
Insights
TL;DR: Insider exercised options and sold part of the resulting shares, capturing a clear profit per share between exercise and sale prices.
The filing shows an exercise of 11,521 employee stock options at $115.67 followed by a disposition of 9,570 shares at $177.20 on the same date, indicating the reporting person realized a per-share spread of $61.53 before taxes and fees. Remaining direct holdings are 12,853 shares. For investors, this is a routine monetization of vested options by a senior executive rather than a corporate event; it slightly increases public float but has no direct impact on fundamentals. The timing and size are consistent with option exercise and partial sale practices for executives.
TL;DR: Transaction appears to follow standard option exercise and reporting procedures, with no indications of policy breaches.
The Form 4 discloses exercised options granted 02/13/2020 that vested on the third anniversary, consistent with the stated vesting schedule. A portion of shares was sold the same day, a common approach to cover exercise costs and taxes. The filing was executed by an attorney-in-fact and signed on 09/03/2025, meeting procedural requirements. There is no information in the filing suggesting reliance on a Rule 10b5-1 plan or other pre-arranged sale instructions; that box was not checked in the provided text.
Riepilogo delle operazioni di insider per Johnson & Johnson (JNJ): Elizabeth Forminard, Executive VP e General Counsel, ha riportato un'operazione relativa a opzioni il 29/08/2025. Ha esercitato 11.521 stock option per dipendenti con prezzo di esercizio di $115,67, acquisendo quindi 11.521 azioni a tale prezzo. Dopo l'esercizio ha venduto 9.570 azioni a $177,20, mantenendo una partecipazione beneficiaria pari a 12.853 azioni ordinarie. Le opzioni erano state originariamente assegnate il 13/02/2020, erano divenute esercitabili al terzo anniversario della concessione e scadono il 13/02/2027. Il modulo Form 4 猫 stato firmato da un procuratore il 03/09/2025.
Resumen de transacciones de insiders de Johnson & Johnson (JNJ): Elizabeth Forminard, Vicepresidenta Ejecutiva y Consejera General, inform贸 actividad relacionada con opciones el 29/08/2025. Ejerci贸 11.521 opciones sobre acciones de empleados con un precio de ejercicio de $115,67, adquiriendo 11.521 acciones a ese precio. Tras el ejercicio vendi贸 9.570 acciones a $177,20, quedando con una titularidad beneficiosa de 12.853 acciones ordinarias. Las opciones fueron otorgadas originalmente el 13/02/2020, se hicieron ejercitables en el tercer aniversario de la concesi贸n y vencen el 13/02/2027. El Formulario 4 fue firmado por un apoderado el 03/09/2025.
Johnson & Johnson(JNJ) 雮措秬鞛� 瓯半灅 鞖旍暯: Elizabeth Forminard(鞝勲 瓴� 氩曤齑濌磩)電� 2025-08-29鞐� 鞓奠厴 甏�霠� 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟. 攴鸽厐電� 頄夓偓臧�瓴� $115.67鞚� 歆侅洂 鞀ろ啞鞓奠厴 11,521欤茧ゼ 頄夓偓頃橃棳 頃措嫻 臧�瓴╈溂搿� 11,521欤茧ゼ 旆摑頄堨姷雼堧嫟. 頄夓偓 頉� 9,570欤茧ゼ 欤茧嫻 $177.20鞐� 毵る弰頃橃棳, 氤挫湢 鞙犾澋甓岇潃 氤错喌欤� 12,853欤茧 雮晿鞀惦媹雼�. 頃措嫻 鞓奠厴鞚� 2020-02-13鞐� 攵�鞐悩鞐堦碃 攵�鞐澕搿滊秬韯� 3欤茧厔 鞁滌爯鞐� 頄夓偓 臧�電ロ晿霃勲 氩犾姢韺呺悩鞐堨溂氅� 毵岅赴鞚检潃 2027-02-13鞛呺媹雼�. Form 4電� 2025-09-03鞐� 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.
R茅sum茅 des transactions d'initi茅s pour Johnson & Johnson (JNJ) : Elizabeth Forminard, vice-pr茅sidente ex茅cutive et conseill猫re g茅n茅rale, a d茅clar茅 une op茅ration li茅e 脿 des options le 29/08/2025. Elle a exerc茅 11 521 options sur actions des salari茅s au prix d'exercice de 115,67 $, acqu茅rant ainsi 11 521 actions 脿 ce prix. Apr猫s l'exercice, elle a vendu 9 570 actions 脿 177,20 $, laissant une participation b茅n茅ficiaire de 12 853 actions ordinaires. Les options exer莽茅es avaient 茅t茅 attribu茅es initialement le 13/02/2020, devenaient exer莽ables au troisi猫me anniversaire de l'attribution et expirent le 13/02/2027. Le formulaire Form 4 a 茅t茅 sign茅 par un mandataire le 03/09/2025.
Insider-Transaktions眉bersicht f眉r Johnson & Johnson (JNJ): Elizabeth Forminard, Executive VP und General Counsel, meldete am 29.08.2025 eine transaktion im Zusammenhang mit Optionen. Sie 眉bte 11.521 Mitarbeiteraktienoptionen zum Aus眉bungspreis von $115,67 aus und erwarb damit 11.521 Aktien zu diesem Preis. Nach der Aus眉bung verkaufte sie 9.570 Aktien zu $177,20 und behielt eine wirtschaftliche Beteiligung von 12.853 Stammaktien. Die ausge眉bten Optionen wurden urspr眉nglich am 13.02.2020 gew盲hrt, wurden am dritten Jahrestag der Gew盲hrung aus眉bbar und laufen am 13.02.2027 ab. Das Formular Form 4 wurde am 03.09.2025 von einem Bevollm盲chtigten unterzeichnet.
FAQ
What did Elizabeth Forminard report on Form 4 for JNJ?
How many JNJ shares does the reporting person own after the transaction?
What were the exercise and sale prices reported on the Form 4 (JNJ)?
When were the underlying options granted and when do they expire?
Was the Form 4 filed and signed appropriately for JNJ insider reporting?
